Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1.19M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
141K
-
Shares change
-
-49.1K
-
Total reported value, excl. options
-
$156K
-
Value change
-
-$71.5K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$1.11
Significant Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q3 2023
13 filings reported holding NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141K shares
of 1.19M outstanding shares and own 11.86% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (49.4K shares), VANGUARD GROUP INC (38.9K shares), NewEdge Advisors, LLC (32.1K shares), RENAISSANCE TECHNOLOGIES LLC (10.3K shares), Tower Research Capital LLC (TRC) (7.43K shares), VALLEY NATIONAL ADVISERS INC (869 shares), JPMORGAN CHASE & CO (788 shares), MORGAN STANLEY (781 shares), BlackRock Inc. (103 shares), and WELLS FARGO & COMPANY/MN (55 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.